Introduction Patients with chronic hepatitis C virus (HCV) infection have a variable response to antiviral therapy with pegylated interferon and ribavirin. Influences include age, gender, viral genotype, viral load, severity of liver disease and coinfection. Around 45% of patients with viral genotype 1(G1) infection respond compared with 70%e80% with genotype 2/3. Recently a human IL28B polymorphism has been found to predict response in patients with G1 infection. There is little data on this from Europe and a study of IL28B polymorphisms in patients with G1 infection treated in Glasgow was conducted. Methods Sequential Caucasian patients with G1 chronic HCV who had been treated with combination antiviral therapy were studied. Responses were classified as sustained viral response (SVR), relapse (R) or non-responder (NR). None had coinfection. Data on age, gender, viral load, duration of therapy and severity of liver disease (Ishak fibrosis stage <4 or $4) were collected. Individuals were genotyped for IL28B polymorphism rs12979860 using TaqMan Ò , Drug Metabolism Genotyping Assays and reported as CC, CT or TT. Abstract PMO-183 Figure 1 Characteristics of study subjects
Conclusion
The IL28B polymorphism is a useful and cheap assay allowing some prediction of response to antiviral therapy in patients with G1 chronic HCV infection.
Competing interests None declared. Introduction Quality Assurance Guidelines for colonoscopy in the Bowel Cancer Screening Programme recommend tattooing of all lesions that may require later surgical or endoscopic localisation, using local protocols as guidance. 1 The St. Mark's Hospital colonoscopic tattooing protocol stated that all suspicious lesions should be tattooed, with the exception of those in the caecum and within 20 cm of the anal verge. Three tattoos should be placed (1208 apart, close to the lesion) and distal to lesions proximal to the splenic flexure (SpFlx). Left sided lesions should have tattoos placed proximal to the lesion. Our aim was to audit compliance with the tattooing protocol in patients undergoing surgery for colorectal neoplasia.
Methods We reviewed endoscopy reports of all patients who had surgery for colorectal neoplasia during a 12-month period. The report was deemed fully compliant if the following were clearly documented: location of the tattoos, correct location of the tattoos, the number of tattoos placed and a correct number of tattoos placed, hence, scoring 4/4. Non-compliance was defined if none of the parameters was mentioned and partial compliance was awarded to those scoring between one and three points. Results 155 patients were identified, of which 114 had reports available. The overall compliance with the protocol was observed in 71 cases (62%) whereas 19 cases (17%) were partially compliant and 24 cases (21%) were non-compliant. Rates for full, partial and incomplete compliance were better for patients diagnosed though the BCSP (71% 26% and 3% respectively) when compared to those diagnosed through non-screening (58%, 13% and 29% respectively). Incomplete documentation (22 cases) and inability to place tattoos proximal to obstructing lesions (19 cases) were the major causes of reduced compliance. Conclusion Educational intervention is necessary to address poor documentation. However, changes to our protocol are also required. We have therefore revised our protocol recommending that all tattoos should be placed distal to the lesion regardless of the anatomical position.
Competing interests None declared. Introduction The mortalitiy associated with gastrointestinal bleeding is around 10%, a figure which has remained roughly constant despite continuing innovation in therapy. The use of injection, thermocoagulation, and endo-clips is widely practiced in the context of bleeding duodenal ulcers. However a number of patients will re-bleed in spite of dual or even triple therapy. In cases where co-morbidity precludes surgical intervention further therapeutic options may be non-existent. Methods We describe a case series of five patients with multiple comorbidity who presented with upper gastrointestinal haemorrhage from duodenal lesions. A variety of therapeutic modalities were employed that is, injection with Adrenaline, thermocoagulation or endoclips. Unfortunately haemostasis was not achieved and surgical intervention deemed inappropriate. Our technique involves tamponade with a 18 mm CRE (constant radial expansion) balloon inflated in the duodenum. The gastroscope with the deflated balloon is passed via the pylorus. The balloon is then inflated keeping the proximal portion of the balloon under direct vision at all times to ensure correct placement. Tamponade is maintained for up to 50 min. Results This procedure achieved haemostasis in all five cases. The tamponade was maintained for a total of between 10 and 50 min. Conclusion Duodenal tamponade to control Haemorrhage has been described previously only twice and has required either specialist equipment 1 or surgical intervention. 2 The CRE balloon is readily available within most endoscopy units and therefore no expenditure is required to use this new modality. In addition the technique is easily learnt and can be readily applied to lesions whose orientation makes targeted intervention difficult. Tamponade is a useful adjunct and may prove lifesaving in an otherwise hopeless situation.
Introduction Colonoscopic removal of large colorectal polyps, sessile or pedunculated, can pose a challenge. Techniques most commonly used are hot snare polypectomy or endoscopic mucosal resection using electrocautery snare. The bigger the size of the polyp greater the skill needed to avoid complications. The potential complications are bleeding and perforation. According to the British Society of Gastroenterology guidelines post polypectomy bleeding requiring transfusion should be <1:100 (for >1 cm polyps) and post polypectomy perforation rate should be <1:500. Methods A retrospective audit was taken between the dates of October 2009 to October 2010 and included patients who had large polyps, defined as polyps equal to and >20 mm in size, removed from the colorectal region by various colonoscopists during their routine colonoscopy lists in a district general hospital. The size of the polyp was confirmed from both the colonoscopy and histology report. Results In total 64 patients with large colorectal polyps were treated. Majorities were pedunculated (n¼49) and the rest were sessile (n¼15). In the group of patients who had pedunculated polyp, 29 were male and 20 were female with a mean age of 62.72 years. The average size of the polyp was 26.22 mm (range:
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